Time window and “tissue window”: two approaches to assist decision-making in strokes
- 197 Downloads
Intravenous alteplase given in an appropriate time window has been recommended in guidelines and effects are on the decline over time. In general, the clinical decision is primarily based on whether ischemic stroke patients are sent to hospitals within the time window. However, some patients sent to the hospital over time limitations are eligible to receive intervention for recanalization due to good collateral circulation. In this dilemma, “tissue window” can be more reliable, which means using the penumbra as a major criterion for patient recruitment. Hence, we herein aim to address how could “tissue window” be a complementary approach when it does not conform to the time window’s indication and affirming value of the later one. Some efforts obeying the time window are discussed first. In the later sections, we give the details of the definition of “tissue window”, and then compare various neuroimaging techniques to determine the penumbra and summarize favorable patterns. Finally, we will focus on how the “tissue window” extends the therapeutic time window under specific circumstances.
KeywordsBrain ischemic Thrombolytic therapy Neuroimaging Diffusion magnetic resonance imaging Penumbra
This review was supported by Grants from Guangdong Techpool Bio-Pharmaceutical Company Limited.
Compliance with ethical standards
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- 7.Peter SJM, Richard IL, Martin D, Graham V, Anna C et al (2012) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. The Lancet 379:2352–2363. https://doi.org/10.1016/S0140-6736(12)60768-5 CrossRefGoogle Scholar
- 8.Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P et al (2010) Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 41:2254. https://doi.org/10.1161/STROKEAHA.110.592535 CrossRefGoogle Scholar
- 13.Molina CA, Ribo M, Rubiera M, Santamarina E, Delgado-Mederos R, Maisterra O et al (2008) TNK induces faster MCA recanalization and leads to better short- and long-term clinical outcome than native tPA. The TNK-tPA reperfusion stroke study. Stroke 39:563 (Abstract) Google Scholar
- 15.Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG et al (2012) Solitaire flow restoration device versus the MERCI retriever in patients with acute ischaemic stroke (SWIFT): A randomised, parallel-group, non-inferiority trial. The Lancet 380:1241–1249. https://doi.org/10.1016/S0140-6736(12)61384-1 CrossRefGoogle Scholar
- 16.Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA et al (2012))TREVO versus MERCI retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. The Lancet 2012 380(12):1231–1240. https://doi.org/10.1016/S0140-6736(12)61299-9 CrossRefGoogle Scholar
- 19.Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM et al (2015) Solitaire™ with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke (SWIFT PRIME) trial: Protocol for a randomized, controlled, multicenter study comparing the solitaire revascularization device with iv tPA alone in acute ischemic stroke. Int J Stroke Off J Int Stroke Soci 10:439–448. https://doi.org/10.1111/ijs.12459 CrossRefGoogle Scholar
- 21.Kunz A, Ebinger M, Geisler F, Rozanski M, Waldschmidt C, Weber JE et al (2016) Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry study. Lancet Neurol 15:1035–1043. https://doi.org/10.1016/S1474-4422(16)30129-6 CrossRefGoogle Scholar
- 22.Mazighi M, Serfaty JM, Labreuche J, Laissy JP, Meseguer E, Lavallée PC et al (2009) Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 8:802. https://doi.org/10.1016/S1474-4422(09)70182-6 CrossRefGoogle Scholar
- 25.Warach SJ, Luby M, Albers GW, Bammer R, Bivard A, Campbell BC et al (2016) Acute stroke imaging research roadmap III imaging selection and outcomes in acute stroke reperfusion clinical trials: Consensus recommendations and further research priorities. Stroke 47:1389. https://doi.org/10.1161/STROKEAHA.115.012364 CrossRefGoogle Scholar